Open study of quadrivalent VN-100 in Japanese healthy volunteers

DAIICHISANKYO Co.,Ltd.0 个研究点目标入组 150 人开始时间: 2014年7月23日最近更新: 2023年10月17日

适应症

试验速览

阶段: 3 期
状态: 已完成
发起方
入组人数: 150

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

As a result of 2nd intradermal vaccinated of quadrivalent VN-100 in healthy Japanese 13 years and older, no serious AEs or AEs leading to this study discontinuation occurred. Therefore we thought there was no serious issues with safety. In addition, HI antibody titer, SRH antibody titer, and neutralizing antibody titer increased after vaccinated of quadrivalent VN-100, confirming good immunogenicity.

研究设计

研究类型: Interventional

入排标准

年龄范围: >= 13age old 至 ot applicable（—）
性别: All

入选标准

•Japanese healthy volunteers

排除标准

•1) Subjects with history of seasonal influenza in the past 6 months
•2) Subjects with history of seasonal influenza vaccination in the past 6 months

研究者

发起方

DAIICHISANKYO Co.,Ltd.

相似试验

已完成

3 期

VN-100 Ph3 non-inferiority studyProphylaxis of influenza infection

JPRN-jRCT2080222443DAIICHISANKYO Co.,Ltd.901

已完成

3 期

Open study of quadrivalent VN-100 in healthy childreProphylaxis of influenza infection

JPRN-jRCT2080222939DAIICHISANKYO Co.,Ltd.73

已完成

1 期

Safety and Immunogenicity of V114 in Healthy Japanese InfantsPrevention of Pneumococcal Infections

JPRN-jRCT2080224598MSD K.K.133

已完成

1 期

VN-100 Ph1/2

JPRN-jRCT2080222050DAIICHISANKYO Co.,Ltd.600

未知

2 期

Clinical trial of VN-0104 in Japanese healthy adult volunteersProphylaxis of influenza infection

JPRN-jRCT2080222536DAIICHISANKYO Co.,Ltd.50